Abstract

Here we studied HLA blocks and haplotypes in a group of 218 Lacandon Maya Native American using a high-resolution next generation sequencing (NGS) method. We assessed the genetic diversity of HLA class I and class II in this population, and determined the most probable ancestry of Lacandon Maya HLA class I and class II haplotypes. Importantly, this Native American group showed a high degree of both HLA homozygosity and linkage disequilibrium across the HLA region and also lower class II HLA allelic diversity than most previously reported populations (including other Native American groups). Distinctive alleles present in the Lacandon population include HLA-A*24:14 and HLA-B*40:08. Furthermore, in Lacandons we observed a high frequency of haplotypes containing the allele HLA-DRB1*04:11, a relatively frequent allele in comparison with other neighboring indigenous groups. The specific demographic history of the Lacandon population including inbreeding, as well as pathogen selection, may have elevated the frequencies of a small number of HLA class II alleles and DNA blocks. To assess the possible role of different selective pressures in determining Native American HLA diversity, we evaluated the relationship between genetic diversity at HLA-A, HLA-B and HLA-DRB1 and pathogen richness for a global dataset and for Native American populations alone. In keeping with previous studies of such relationships we included distance from Africa as a covariate. After correction for multiple comparisons we did not find any significant relationship between pathogen diversity and HLA genetic diversity (as measured by polymorphism information content) in either our global dataset or the Native American subset of the dataset. We found the expected negative relationship between genetic diversity and distance from Africa in the global dataset, but no relationship between HLA genetic diversity and distance from Africa when Native American populations were considered alone.

Details

Title
Diversity of HLA Class I and Class II blocks and conserved extended haplotypes in Lacandon Mayans
Author
Barquera Rodrigo 1   VIAFID ORCID Logo  ; Zuniga, Joaquin 2   VIAFID ORCID Logo  ; Flores-Rivera, José 3 ; Corona, Teresa 3   VIAFID ORCID Logo  ; Penman, Bridget S 4 ; Hernández-Zaragoza, Diana Iraíz 5 ; Soler, Manuel 6 ; Jonapá-Gómez Letisia 7 ; Mallempati, Kalyan C 8 ; Yescas Petra 9 ; Ochoa-Morales, Adriana 9 ; Barsakis Konstantinos 10 ; Aguilar-Vázquez, José Artemio 11 ; García-Lechuga Maricela 6 ; Mindrinos, Michael 12 ; Yunis María 13 ; Jiménez-Alvarez, Luis 14 ; Mena-Hernández, Lourdes 6 ; Ortega, Esteban 15 ; Cruz-Lagunas, Alfredo 14   VIAFID ORCID Logo  ; Tovar-Méndez, Víctor Hugo 6 ; Granados, Julio 6 ; Fernández-Viña Marcelo 16 ; Yunis Edmond 17 

 Department of Archaeogenetics, Max Planck Institute for the Science of Human History (MPI-SHH), Jena, Germany (GRID:grid.469873.7) (ISNI:0000 0004 4914 1197); Laboratory of Molecular Genetics, Escuela Nacional de Antropología e Historia (ENAH), Mexico City, Mexico (GRID:grid.462439.e) (ISNI:0000 0001 2169 9197) 
 Department of Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas (INER), Mexico City, Mexico (GRID:grid.419179.3) (ISNI:0000 0000 8515 3604); Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico (GRID:grid.419886.a) (ISNI:0000 0001 2203 4701) 
 Clinical Laboratory of Neurodegenerative Diseases, Instituto Nacional de Neurología y Neurocirugía “Manuel Velasco Suárez”, Mexico City, Mexico (GRID:grid.419204.a) (ISNI:0000 0000 8637 5954) 
 University of Warwick, School of Life Sciences, Coventry, United Kingdom (GRID:grid.7372.1) (ISNI:0000 0000 8809 1613) 
 Laboratory of Molecular Genetics, Escuela Nacional de Antropología e Historia (ENAH), Mexico City, Mexico (GRID:grid.462439.e) (ISNI:0000 0001 2169 9197); Immunogenetics Unit, Técnicas Genéticas Aplicadas a la Clínica (TGAC), Mexico City, Mexico (GRID:grid.462439.e) 
 Department of Transplantation, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMSZ), Mexico City, Mexico (GRID:grid.416850.e) (ISNI:0000 0001 0698 4037) 
 Public Health State Laboratory for Chiapas, Tuxtla Gutierrez, Chiapas, Mexico (GRID:grid.416850.e) 
 Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, USA (GRID:grid.416850.e); Biology Department, University of Crete, Heraklion, Greece (GRID:grid.8127.c) (ISNI:0000 0004 0576 3437) 
 Department of Neurogenetics and Molecular Biology, Instituto Nacional de Neurología y Neurocirugía “Manuel Velasco Suárez”, Mexico City, Mexico (GRID:grid.419204.a) (ISNI:0000 0000 8637 5954) 
10  Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, USA (GRID:grid.419204.a); Department of Pathology, Stanford University, USA (GRID:grid.419204.a) 
11  Clinical Analysis Laboratory, Unidad Médica Familiar (UMF) No. 23, Instituto Mexicano del Seguro Social (IMSS), Tuxtla Gutiérrez, Mexico (GRID:grid.419157.f) (ISNI:0000 0001 1091 9430) 
12  Stanford Genome Technology Center, Palo Alto, USA (GRID:grid.168010.e) (ISNI:0000000419368956) 
13  Department of Cancer Immunology and Virology, Dana Farber Cancer Institute, Harvard Medical School, Boston, USA (GRID:grid.168010.e) 
14  Department of Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas (INER), Mexico City, Mexico (GRID:grid.419179.3) (ISNI:0000 0000 8515 3604) 
15  The William Harvey Research Institute, Barts and London School of Medicine, Queen Mary University of London, London, United Kingdom (GRID:grid.4868.2) (ISNI:0000 0001 2171 1133) 
16  Department of Pathology, Stanford University, USA (GRID:grid.416850.e) 
17  Department of Cancer Immunology and Virology, Dana Farber Cancer Institute, Harvard Medical School, Boston, USA (GRID:grid.416850.e) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2362210870
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.